Evidence mapPaperPMID 42444621Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

PEAR1 Promotes Glucose Metabolism Reprogramming in Sepsis-Associated Acute Lung Injury via AARS1-Mediated HIF-1α Lactylation.

Shuai Li, Zongqing Lu, Pu Fang, Qingqing Pang, Xianghui Wu, Bo Wang, Min Liang, Jingjing Pan, Haobo Kong, Haijian Cai and 6 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Shuai LiDepartment of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, China.ORCID https://orcid.org/0000-0001-6664-6507
Zongqing LuDepartment of Intensive Care Unit, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Pu FangDepartment of Intensive Care Unit, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Qingqing PangDepartment of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Xianghui WuDepartment of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Bo WangDepartment of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Min LiangDepartment of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Jingjing PanDepartment of Respiratory Intensive Care Unit, Anhui Chest Hospital, Hefei, China.
Haobo KongDepartment of Respiratory Intensive Care Unit, Anhui Chest Hospital, Hefei, China.
Haijian CaiCenter For Scientific Research, Anhui Medical University, Hefei, China.
Juanjuan LiDepartment of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Jiaying KangDepartment of Pulmonary and Critical Care Medicine, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, China.
Dongsheng WangDepartment of Pulmonary and Critical Care Medicine, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, China.
Dunling XiaDepartment of Emergency Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Mengmeng XuDepartment of Pulmonary and Critical Care Medicine, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, China.
Qinghai YouDepartment of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, China.

Funding

Anhui Natural Science Foundation 2208085MH195China Postdoctoral Science Foundation-Anhui Joint Support Program 2025T027AHHealth Research Youth Project of Anhui Province AHWJ2023A30280National Natural Science Foundation of China 82400047Research initiation fund for doctors of the first affiliated hospital of USTC RC2023027
6 · The paper itself

Abstract

Sepsis-associated acute lung injury (S-ALI), in which pulmonary microvascular endothelial cells act as key drivers of disease progression by increasing vascular permeability and ultimately exacerbating lung injury, is associated with a high mortality rate. Here, we report that PEAR1 expression and vascular permeability are increased in the lung tissues of septic mice. Pear1 knockdown markedly reduces pulmonary vascular permeability and consequently attenuates lung injury in septic mice. Mechanistically, PEAR1 promotes the AARS1-mediated lactylation of HIF-1α, primarily at lysine 172 (K172). This lactylation event, in turn, increases the affinity of HIF-1α for importin α, thereby facilitating HIF-1α nuclear translocation. Importantly, HIF-1α K172 lactylation promotes glycolysis, and glycolysis-derived lactate further drives H3K18 lactylation. In addition, this lactate-dependent histone modification is enriched at the Pear1 promoter, resulting in further increases in glycolysis and pulmonary vascular permeability. In vivo, both Pear1 knockout and the targeted delivery of Pear1 siRNA to inflammatory vascular endothelial cells using E-selectin-binding peptide-modified liposomes ameliorate ALI, and improve survival in mice with polymicrobial sepsis. Our study identifies K172 as a previously unreported lactylation site on HIF-1α and shows that PEAR1 promotes AARS1-mediated HIF-1α lactylation, enhances glycolysis, and increases H3K18la enrichment at the Pear1 promoter, thereby forming a positive feedback loop.

Indexed as

glycolysislactylationPEAR1sepsis‐associated acute lung injury

Identifiers

PMID42444621
PMCPMC13366482

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.